Insider at Eli Lilly (LLY) Makes Significant Sale of Stock

Monday, September 18, 2017 10:15 PM ET

Insider at Eli Lilly (LLY) Makes Significant Sale of Stock

There was a significant insider sale of Eli Lilly shares today, as revealed in a filing with the SEC as — Lilly Endowment Inc, 10% Owner — disposed of 190,000 shares in the company having a market value of approximately $15,679,772 There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 825,000 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 1,015,000 shares and have averaged 507,500 shares per transaction over this time period.

The level of buy/sell trading at Eli Lilly is is greater than the 113 peer company average over the last 90-day period. The Pharmaceuticals peer group saw 112 buy/sell trades during this period for an average of 1.0 transactions per company. The number of shares per buy/sell trade for Eli Lilly insiders was also higher. Within the peer group there were 3,142,768 shares purchased and 5,523,434 shares sold with company insiders disposing of 21,256 shares on average.

The data used in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.